Cosciens Biopharma Stock Market Value
| CSCI Stock | 2.78 0.08 2.96% |
| Symbol | COSCIENS |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of COSCIENS Biopharma. If investors know COSCIENS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about COSCIENS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.69) | Revenue Per Share 3.759 | Quarterly Revenue Growth 0.041 | Return On Assets (0.23) | Return On Equity |
The market value of COSCIENS Biopharma is measured differently than its book value, which is the value of COSCIENS that is recorded on the company's balance sheet. Investors also form their own opinion of COSCIENS Biopharma's value that differs from its market value or its book value, called intrinsic value, which is COSCIENS Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because COSCIENS Biopharma's market value can be influenced by many factors that don't directly affect COSCIENS Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between COSCIENS Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if COSCIENS Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, COSCIENS Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
COSCIENS Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to COSCIENS Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of COSCIENS Biopharma.
| 03/16/2023 |
| 03/05/2025 |
If you would invest 0.00 in COSCIENS Biopharma on March 16, 2023 and sell it all today you would earn a total of 0.00 from holding COSCIENS Biopharma or generate 0.0% return on investment in COSCIENS Biopharma over 720 days. COSCIENS Biopharma is related to or competes with Anheuser Busch, Keurig Dr, Universal, Westrock Coffee, Juniata Valley, and Scandinavian Tobacco. COSCIENS Biopharma is entity of United States More
COSCIENS Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure COSCIENS Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess COSCIENS Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0106 | |||
| Maximum Drawdown | 30.84 | |||
| Value At Risk | (6.71) | |||
| Potential Upside | 7.14 |
COSCIENS Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for COSCIENS Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as COSCIENS Biopharma's standard deviation. In reality, there are many statistical measures that can use COSCIENS Biopharma historical prices to predict the future COSCIENS Biopharma's volatility.| Risk Adjusted Performance | 0.008 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | 0.4152 | |||
| Treynor Ratio | 0.0197 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of COSCIENS Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
COSCIENS Biopharma Backtested Returns
COSCIENS Biopharma is very risky at the moment. COSCIENS Biopharma secures Sharpe Ratio (or Efficiency) of 0.013, which signifies that the company had a 0.013 % return per unit of volatility over the last 3 months. We have found twenty-two technical indicators for COSCIENS Biopharma, which you can use to evaluate the volatility of the firm. Please confirm COSCIENS Biopharma's risk adjusted performance of 0.008, and Mean Deviation of 3.64 to double-check if the risk estimate we provide is consistent with the expected return of 0.0673%. COSCIENS Biopharma has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.64, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning COSCIENS Biopharma are expected to decrease at a much lower rate. During the bear market, COSCIENS Biopharma is likely to outperform the market. COSCIENS Biopharma currently shows a risk of 5.17%. Please confirm COSCIENS Biopharma skewness, as well as the relationship between the rate of daily change and period momentum indicator , to decide if COSCIENS Biopharma will be following its price patterns.
Auto-correlation | 0.78 |
Good predictability
COSCIENS Biopharma has good predictability. Overlapping area represents the amount of predictability between COSCIENS Biopharma time series from 16th of March 2023 to 10th of March 2024 and 10th of March 2024 to 5th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of COSCIENS Biopharma price movement. The serial correlation of 0.78 indicates that around 78.0% of current COSCIENS Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.78 | |
| Spearman Rank Test | 0.77 | |
| Residual Average | 0.0 | |
| Price Variance | 4.63 |
COSCIENS Biopharma lagged returns against current returns
Autocorrelation, which is COSCIENS Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting COSCIENS Biopharma's stock expected returns. We can calculate the autocorrelation of COSCIENS Biopharma returns to help us make a trade decision. For example, suppose you find that COSCIENS Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
COSCIENS Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If COSCIENS Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if COSCIENS Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in COSCIENS Biopharma stock over time.
Current vs Lagged Prices |
| Timeline |
COSCIENS Biopharma Lagged Returns
When evaluating COSCIENS Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of COSCIENS Biopharma stock have on its future price. COSCIENS Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, COSCIENS Biopharma autocorrelation shows the relationship between COSCIENS Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in COSCIENS Biopharma.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether COSCIENS Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of COSCIENS Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cosciens Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cosciens Biopharma Stock:Check out COSCIENS Biopharma Correlation, COSCIENS Biopharma Volatility and COSCIENS Biopharma Alpha and Beta module to complement your research on COSCIENS Biopharma. For more detail on how to invest in COSCIENS Stock please use our How to Invest in COSCIENS Biopharma guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
COSCIENS Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.